Related Experiment Video
Updated: Jul 20, 2026
11:12
Nondestructive Monitoring of Degradable Scaffold-Based Tissue-Engineered Blood Vessel Development Using Optical Coherence Tomography
Published on: October 3, 2018
A quantitative method for evaluating the degradation of biologic scaffold materials
Thomas W Gilbert1, Ann M Stewart-Akers, Stephen F Badylak
1McGowan Institute for Regenerative Medicine, University of Pittsburgh, 100 Technology Drive, Suite 200, Pittsburgh, PA 15219, USA.
Biomaterials
|September 5, 2006
Summary
Researchers developed a novel method to track the degradation of extracellular matrix (ECM) scaffolds using carbon-14 labeling. This technique quantifies scaffold breakdown and the fate of its products in tissue engineering.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Naturally derived extracellular matrix (ECM) scaffolds are crucial for tissue engineering and regenerative medicine.
- Existing ECM scaffolds exhibit variability in origin and processing, with limited understanding of their degradation rates and product fate.
- Current methods lack quantitative approaches to assess ECM scaffold degradation and product tracking.
Purpose of the Study:
- To develop a novel, quantitative method for integrally labeling ECM scaffolds with carbon-14 ((14)C).
- To determine the degradation rate and track the fate of degradation products of ECM scaffolds.
- To assess the applicability of the (14)C labeling technique across various tissue types.
Main Methods:
- Integral labeling of ECM scaffolds with radioactive carbon-14 ((14)C).
- Quantification of (14)C levels in various tissues (heart, liver, trachea, pancreas, small intestine, urinary bladder, spleen) using accelerator mass spectrometry.
- Development of a quantitative model to determine ECM scaffold degradation rates and product distribution.
Main Results:
- The (14)C labeling method successfully labeled multiple ECM tissues, including heart, liver, trachea, pancreas, small intestine, and urinary bladder.
- Spleen tissue did not show detectable levels of (14)C after labeling.
- The technique demonstrated high sensitivity, accuracy, and safety, enabling quantitative assessment of ECM degradation and product fate.
Conclusions:
- A novel, sensitive, and accurate method using (14)C labeling was established for quantifying ECM scaffold degradation and tracking products.
- This technique provides the first quantitative model for understanding ECM scaffold breakdown dynamics in tissue engineering.
- The method's applicability across various tissues offers a valuable tool for advancing regenerative medicine research.
